However, several studies have shown that type 2 diabetes is associated with atrial fibrillation, with risk increasing with poor glycaemic control, glycaemic variability, longer diabetes duration, hypertension, and albuminuria. There are conflicting findings on whether type 2 diabetes is an independent risk factor for atrial fibrillation.

Studies have shown that when both conditions coexist, the risk for thromboembolism is increased. The prevalence of both atrial fibrillation and type 2 diabetes has been rising rapidly. At the same time, atrial fibrillation is the most common cardiac arrhythmia with similar outcomes as type 2 diabetes. Type 2 diabetes is a metabolic disorder, with an increased risk of micro- and macrovascular complications such as thromboembolism, stroke and mortality. Individuals with type 2 diabetes with good glycaemic control and normoalbuminuria had slightly increased risk. The excess risk for atrial fibrillation increased with renal complications or with poor glycaemic control. Individuals with type 2 diabetes had an overall 35% higher risk of atrial fibrillation compared to age- and sex-matched controls from the general population. For individuals with HbA1cвЂ‰в‰¤вЂ‰6.9% (в‰¤В 52 mmol/mol)В and normoalbuminuria the excess risk vs controls was still increased, adjusted HR 1.16 (95% CI 1.14вЂ“1.19) pвЂ‰<вЂ‰0.0001. The excess risk of atrial fibrillation in individuals with type 2 diabetes increased with worsening glycaemic control and renal complications. In the fully adjusted Cox regression, the risk of type 2 diabetes on incident atrial fibrillation was 28% greater vs controls, hazard ratio (HR) 1.28 (95% CI 1.26вЂ“1.30), pвЂ‰<вЂ‰0.0001. Women <вЂ‰55В years old with type 2 diabetes had an IRR of 2.36 (95% CI 2.10вЂ“2.66), in relation to controls, whereas the corresponding value for menвЂ‰<вЂ‰55В years old with type 2 diabetes was IRR 1.78 (95% CI 1.67вЂ“1.90). Overall, 8.9% of individuals with type 2 diabetes and 7.0% of controls were diagnosed with atrial fibrillation during follow-up, unadjusted incidence risk ratio (IRR) 1.35 (95% 1.33вЂ“1.36). MethodsДЄ total of 421,855 patients with type 2 diabetes from the Swedish National Diabetes Registry and 2,131,223 controls from the Swedish Population Registry, matched for age, sex and county, were included and followed from Januto December 31, 2013. To examine the incidence of atrial fibrillation in individuals with type 2 diabetes compared with age- and sex-matched controls from the general population and its variation in relation to glycaemic control and renal function.

Type 2 atrial flutter icd 10